RDC — Redcare Pharmacy NV Income Statement
0.000.00%
- €2.64bn
- €2.74bn
- €2.37bn
- 50
- 23
- 76
- 46
Annual income statement for Redcare Pharmacy NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 968 | 1,060 | 1,204 | 1,799 | 2,371 |
Cost of Revenue | |||||
Gross Profit | 220 | 267 | 332 | 440 | 546 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 969 | 1,126 | 1,274 | 1,816 | 2,410 |
Operating Profit | -0.866 | -65.7 | -69.2 | -17.3 | -39 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.9 | -77.9 | -84.1 | -14.3 | -47.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.8 | -74.2 | -77.6 | -11.6 | -46.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -16.8 | -74.2 | -77.6 | -12 | -45.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.8 | -74.2 | -77.6 | -12 | -45.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.88 | -3.01 | -3.75 | -0.299 | -2.25 |
Dividends per Share |